CN1113647A - 心脏恢复剂 - Google Patents

心脏恢复剂 Download PDF

Info

Publication number
CN1113647A
CN1113647A CN94190630A CN94190630A CN1113647A CN 1113647 A CN1113647 A CN 1113647A CN 94190630 A CN94190630 A CN 94190630A CN 94190630 A CN94190630 A CN 94190630A CN 1113647 A CN1113647 A CN 1113647A
Authority
CN
China
Prior art keywords
group
heart function
inosine
purine
heart
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN94190630A
Other languages
English (en)
Chinese (zh)
Inventor
市原和夫
横山弘臣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Factory Inc
Original Assignee
Otsuka Pharmaceutical Factory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Factory Inc filed Critical Otsuka Pharmaceutical Factory Inc
Publication of CN1113647A publication Critical patent/CN1113647A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/167—Purine radicals with ribosyl as the saccharide radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CN94190630A 1993-08-25 1994-08-19 心脏恢复剂 Pending CN1113647A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21009693 1993-08-25
JP210096/93 1993-08-25

Publications (1)

Publication Number Publication Date
CN1113647A true CN1113647A (zh) 1995-12-20

Family

ID=16583754

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94190630A Pending CN1113647A (zh) 1993-08-25 1994-08-19 心脏恢复剂

Country Status (7)

Country Link
EP (1) EP0665016A4 (enExample)
JP (1) JP3057295B2 (enExample)
KR (1) KR960701639A (enExample)
CN (1) CN1113647A (enExample)
CA (1) CA2146242A1 (enExample)
TW (1) TW280772B (enExample)
WO (1) WO1995005832A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732019B1 (fr) * 1995-03-24 1997-06-13 Flamel Tech Sa Spiropyrannes photochromiques, compositions et articles les contenant
US6080849A (en) 1997-09-10 2000-06-27 Vion Pharmaceuticals, Inc. Genetically modified tumor-targeted bacteria with reduced virulence
BR9812079A (pt) 1997-09-10 2000-09-26 Vion Pharmaceuticals Inc Salmonella sp. mutante, lipopolissacarìdeo, processo para inibir o crescimento ou reduzir o volume de um câncer de tumor sólido, composição farmacêutica, e, processo aperfeiçoado para selecionar alterações genéticas em uma bactéria.
JP5333970B2 (ja) * 2007-03-20 2013-11-06 国立大学法人大阪大学 心筋梗塞の予防および／または治療薬
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1206341B (it) * 1984-02-16 1989-04-14 Crinos Industria Farmaco Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
ZA892928B (en) * 1988-04-25 1991-01-30 Pro Neuron Inc Pharmaceutical compositions containing deoxyribonucleosides for wound healing
JPH04242830A (ja) * 1991-01-08 1992-08-31 Brother Ind Ltd 故障診断装置
JP2714728B2 (ja) * 1991-07-01 1998-02-16 株式会社大塚製薬工場 腸粘膜萎縮抑制剤
IT1251160B (it) * 1991-08-07 1995-05-04 Bioresearch Spa Impiego di composti adenosinici nel trattamento dell'ischemia
JP3032053B2 (ja) * 1991-09-06 2000-04-10 日水製薬株式会社 ウリジン誘導体及びこれを含有する医薬

Also Published As

Publication number Publication date
EP0665016A1 (en) 1995-08-02
EP0665016A4 (en) 1998-01-21
TW280772B (enExample) 1996-07-11
CA2146242A1 (en) 1995-03-02
JP3057295B2 (ja) 2000-06-26
KR960701639A (ko) 1996-03-28
WO1995005832A1 (en) 1995-03-02

Similar Documents

Publication Publication Date Title
US5095027A (en) Method for treating reperfusion injury employing L-2-oxothiazolidine-4-carboxylic acid
PT87039B (pt) Processo para a preparacao de uma composicao farmaceutica para tratamento de infeccoes virais humanas
JP2002363097A5 (enExample)
AU2004216891B2 (en) Use of adenosine receptor agonists in therapy
TW200808305A (en) Lactate and calcium containing pharmaceutical composition and uses thereof
Burke et al. Acute amphotericin B overdose
CN1113647A (zh) 心脏恢复剂
JP3253302B2 (ja) ３−ジアルキルアミノエトキシベンゾイル−ベンゾフランを含有する非経口溶液
JPH04506667A (ja) 甲状腺ホルモン心臓治療
US5852000A (en) Cardiac rehabilitation agent
KR20070015403A (ko) 근이완 촉진제 및 근이완 부전등의 근조직계 질병의 치료약
JP4890266B2 (ja) Ｄ−リボースを含む、麻酔からの回復のための医薬
EP1062948B1 (en) Remedies for non cardiogenic diastolic dysfunction
JPWO1995005832A1 (ja) 心機能回復剤
JPH03135918A (ja) 免疫賦活剤
WO1987001593A1 (en) Continuous intravenous infusion of adenosine to human patients, a unit dosage form of adenosine and use of adenosine for the manufacture of medicaments
US6407113B1 (en) Medicament for treatment of diastolic dysfunction
WO1995005834A1 (en) Use of 2-deoxycoformycin (pentostatin) for treating cerebral and cardiovascular disorders
JP2001514229A (ja) 心臓血管疾患の阻害剤としての硫酸化されたオリゴ糖の使用
JP5596779B2 (ja) 急性心筋梗塞に対する初期対応におけるリボースの使用
CA2160689C (en) New method of treatment
JP2008526816A5 (enExample)
WO1996037205A1 (en) Remedy for endotoxinemia and multiple organ failure induced thereby
JPH0329765B2 (enExample)
Jang et al. Nicardipine augments local myocardial perfusion after coronary artery reperfusion in dogs

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication